Europe — EMA
Octreoscan (Indium In-111 Pentetreotide)
Indium In-111 pentetreotide, the active ingredient in Octreoscan, is a somatostatin analog presented as a radiopharmaceutical for intravenous use.
Request sourcing
What is Indium In-111 Pentetreotide?
Indium In-111 pentetreotide, the active ingredient in Octreoscan, is a somatostatin analog presented as a radiopharmaceutical for intravenous use. It is employed in diagnostic imaging to locate neuroendocrine tumors and related lesions in adult patients. GNH USA supplies Octreoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and clinics worldwide.
GNH USA supplies Octreoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and clinics worldwide.
What is Indium In-111 Pentetreotide used for?
Octreoscan is used in the context of somatostatin receptor imaging for neuroendocrine tumor assessment.
- Gastroenteropancreatic neuroendocrine tumors: Helps to identify the extent of disease and guide therapeutic planning. - Carcinoid syndrome : Assists in detecting somatostatin‑receptor positive lesions that may benefit from peptide‑peptide therapy.\n- Metastatic metastasis : Provides a whole‑body survey of somatcin …
What are the side effects of Indium In-111 Pentetreotide?
Common Side Effects:
- ...
What precautions apply to Indium In-111 Pentetreotide?
...
